Dmitry Foxham

Dmitry Foxham is the Chief Operating Officer (COO) at Cambridge Molecular, a computational drug discovery company.1 As COO, he plays a key role in the company's leadership and operations.

Professional Background

Dmitry Foxham is not only the COO but also a co-founder of Cambridge Molecular.1 The company focuses on developing new ways of discovering medicines using computational methods.1 This suggests that Foxham likely has expertise in both the business and scientific aspects of drug discovery.

Company Information

Cambridge Molecular is based in the United Kingdom, specifically in Cambridge.2 As a computational drug discovery company, they are working on innovative approaches to identify potential new medicines.1 The company appears to be relatively young, as it is still in the startup or growth phase based on the available information.

LinkedIn Profile

Dmitry Foxham's LinkedIn profile can be found under the username dmitry-foxham-96665a174.1 This profile likely contains more detailed information about his professional experience, education, and accomplishments in the field of drug discovery and biotechnology.

While specific details about Dmitry Foxham's background and career history are limited in the provided search results, his role as COO and co-founder of a computational drug discovery company indicates that he has significant expertise in the intersection of technology and pharmaceutical research.